Research Article
Molecular Targets of Shenqi Dihuang, A Traditional Chinese Herbal Medicine, and Its Potential Role in Renal Cell Carcinoma Therapy
Figure 4
(a)–(b) The difference in immune cells between low- and high-risk
groups. (c) Survival analysis based on the resting T cells expression
level. (d) Survival analysis based on the resting mast cells expression
level. (e) Survival analysis based on the expression monocytes level.
(f) Survival analysis based on the regulatory T cells expression level.
(g) Survival analysis based on the activated T cells expression
level.
| (a) |
| (b) |
| (c) |
| (d) |
| (e) |
| (f) |
| (g) |